Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus pen needles improves injection stability and user comfort versus conventional narrow hubs in laboratory bench tests. The study measured...
Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS
Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced that new clinical and real-world data from its integrated-by-design VARIPULSE™ Platform in pulsed field...
Biomom Reinvents “Snow” with Five-Layer Safety Packaging — Stronger Protection and Greater Convenience for Kids’ Probiotics
SEOUL, South Korea, Nov. 3, 2025 /PRNewswire/ -- Health supplement brand Biomom has introduced upgraded, hygienic packaging for its flagship probiotic "Biomom Snow." The renewal features five-layer safety stick and pillow packaging designed to enhance probiotic protection and ensure a more convenient, safer experience for consumers. Biomom Snow contains 10 billion CFU probiotics per stick, formulated with 19 MFDS-approved strains,...
GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’
YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been published in the international journal Vaccine. BARYTHRAX is the world's first recombinant anthrax vaccine, jointly developed...
Akeso’s Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer
HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) from China's National Medical Products Administration (NMPA). The Phase III multicenter, randomized, double-blind...
MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 2025
MEDAN, Indonesia, Nov. 3, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held in Medan, Indonesia. The event serves as one of the largest tourism exhibitions in the country, gathering travel agents, airlines, hotels, medical institutions, and tourism partners under one roof to...
OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALISTS THROUGH WEEK-LONG HEALTHCARE ACTIVATION
SEEB, Oman, Nov. 3, 2025 /PRNewswire/ -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first major Middle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients with Malaysian medical specialists through public exhibitions, clinical consultations and professional exchange, demonstrating Malaysia's "Healing Meets Hospitality" approach to international healthcare....
Oxford Instruments introduces the witec360 Raman Microscope with Hexalight Spectrometer to advance research in Singapore and across Southeast Asia
LONDON, Nov. 3, 2025 /PRNewswire/ -- Oxford Instruments today announced the launch of its witec360 Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers unprecedented optical performance, automation, and flexibility for research institutions and advanced industries across Singapore and the wider Asia region. ...
Caregility and MOD3RN Care Partner to Modernise Healthcare Delivery in Australia
WALL, N.J. and BARANGAROO, Australia, Nov. 3, 2025 /PRNewswire/ -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered solutions, today announced a strategic reseller partnership with MOD3RN Care, a leading Australia-based technology solutions provider. The collaboration aims to accelerate the...
Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated the phase 2/3 clinical trial and completed the first patient first dose at the 2nd Affiliated Hospital of Hebei Medical University. Previously (in July 2025), CB03-154...
